Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer is a research paper published in Cancer Letters (2023). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P01 CA217798
National Cancer Institute
Grant: P20 GM121316
National Cancer Institute
Grant: P30 CA036727
National Cancer Institute
Grant: R01 CA208108
National Cancer Institute
Grant: R01 CA256973
National Cancer Institute
Grant: R01 CA259080
National Cancer Institute
Grant: U01 CA210240
National Institutes of Health
Grant: 5R01CA259080-02
Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer
National Institutes of Health
Grant: 5R01CA256973-02
Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer
National Institutes of Health
Grant: 5P01CA217798-04
Pancreatic Cancer Metastasis
National Institutes of Health
Grant: 5U01CA210240-07
Pancreatic Cancer Detection Consortium
National Institutes of Health
Grant: 5P20GM121316-03
Nebraska Center for Molecular Target Discovery and Development
National Institutes of Health
Grant: 5P30CA036727-23
CORE--Confocal Microscopy
National Institutes of Health
Grant: 5R01CA208108-03
MUC16 in Pancreatic Cancer Progression and Metastasis
National Institutes of Health
Fred and Pamela Buffett Cancer Center
FWCI
2.63
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals